Sun Pharmaceutical Industries expands the label for Ilumya (tildrakizumab-asmn) to include treatment for adults with active ...

Strides Pharma reports a 17.1% YoY revenue increase in Q2, reaching ₹1,429 crore. Net profit rises 2% amidst stronger growth ...

Sun Pharmaceutical Industries has been ordered to cease production of ophthalmic products at its Assam plant due to quality ...

Merck is set to increase its revenue forecast for the next decade due to successful clinical trials and new acquisitions, ...

India's pharmaceutical exports rose 3% to $8.04 billion in Q2 2027-28, driven by strong demand in European markets, ...

The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...

Sandoz, the Swiss generic drugmaker, adjusts its sales growth forecast to 5-6% due to supply constraints, impacting investor ...

Cybersecurity experts emphasize the significance of human oversight in AI-driven security and the critical need for effective ...

In response to safety issues surrounding cough syrups in India, the CDSCO mandates strict monitoring of high-risk solvents ...